Skip to content

dexmedetomidine with intravenous lidocaine in colonoscopy

Comparison of the effect of dexmedetomidine with intravenous lidocaine in patients undergoing colonoscopy under sedation with propofol-fentanyl

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220706055402N2
Enrollment
120
Registered
2023-02-11
Start date
2023-01-21
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonoscopy,sedation. Failed moderate sedation during procedure

Interventions

Intervention 1: Intervention group: Intravenous lidocaine is injected with an initial dose of 1.5 mg/kg and a maintenance dose of 1 mg/kg/h, in addition to propofol 0.5 mg/kg and 1 microgram/kg of fen

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Colonoscopy candidate patients who need anesthesia In the age range of 18 to 65 years Not suffering from cardiovascular diseases, kidney or liver failure No drug addiction Patient willingness to participate in the study

Exclusion criteria

Exclusion criteria: The patient's unwillingness to participate in the study Intestinal perforation during the procedure Esophageal or stomach or intestinal bleeding during the procedure Changing the type of procedure during colonoscopy or the need for surgery during the procedure

Design outcomes

Primary

MeasureTime frame
Level of sedation. Timepoint: From start to end of colonoscopy. Method of measurement: Ramsay Sedation Scale.;Amount of pain. Timepoint: From start to one hour after colonoscopy. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Moftakhar

Ahvaz University of Medical Sciences

moftakhar-f@ajums.ac.ir+98 61 3338 3372

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026